Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF‐1 axis

Karthik Narayanan(Post Graduate Institute of Medical Education and Research), R. K. Marwaha, Rama Walia(Post Graduate Institute of Medical Education and Research), Deepak Bansal(Post Graduate Institute of Medical Education and Research), Neelam Varma(Nagpur Institute of Technology), Anil Bhansali(Post Graduate Institute of Medical Education and Research), Naresh Sachdeva(Post Graduate Institute of Medical Education and Research)
Pediatric Blood & Cancer
January 15, 2013
Cited by 85


Related Papers